IP Library › Assignment 035364/0396
Patent Assignment
Reel/Frame 035364/0396

Security Agreement

Recorded: 2015-04-02 Pages: 81
Assignors
GLYCYX PHARMACEUTICALS, LTD.
Executed: 2015-04-01
SALIX PHARMACEUTICALS, INC.
Executed: 2015-04-01
SALIX PHARMACEUTICALS, LTD.
Executed: 2015-04-01
SANTARUS, INC.
Executed: 2015-04-01
Assignee
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE, NEW YORK, NEW YORK, 10019
Covered Properties (230)
A Novel Formulation , Omeprazole Antacid Complex-Immediate Release for Rapid and Sustained Suppression of Gastric Acid
Pharmaceutical Compositions for Inhibiting Acid Secretion
Pharmaceutical Formulation and Method for Treating Acid-Caused Gastrointestinal Disorders
Colonic Purgative Composition with Soluble Binding Agent
Combination of Proton Pump Inhibitor, Buffering Agent, and Nonsteroidal Anti-Inflammatory Drug
A Novel Formulation, Omeprazole Antacid Complex-Immediate Release for Rapid and Sustained Suppression of Gastric Acid
Combination of Proton Pump Inhibitor, Buffering Agent, and Prokinetic Agent
Purgative Composition and Uses Thereof
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Polyethylene Glycol Colonic Purgative Composition
Balsalazide Formulations and Manufacture and Use Thereof
Rifaximin Anti-Rectal Dysfunction Preparation
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Compositions and Methods for the Treatment of Radiation Proctosigmoitis
Novel Formulations of Proton Pump Inhibitors and Methods of Using These Formulations
Forms of Rifaximin and Uses Thereof
Methods for Treating Bowel Diseases
Methods of Treating Bowel Disease by Administering a Bowel Cleanser and an Antibiotic
Methods of Treating Hepatic Encephalopathy
Compositions for Bowel Preparation and Methods of Use Thereof
Methods for Treating Hepatic Encephalopathy
Modulation of Systemic Exposure to Rifaximin
Methods for Treating Irritable Bowel Syndrome (Ibs)
Methods of Treating Diseases with Proanthocyanidin Oligomers Such as Crofelemer
Forms of Rifaximin and Uses Thereof
Methods for Treating Infection
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Methods of Treating Hepatic Encephalopathy
New Forms of Rifaximin and Uses Thereof
Formulations of Rifaximin and Uses Thereof
Formulations of Rifaximin and Uses Thereof
Methods and Compositions for Treating Hiv-Associated Diarrhea
Forms of Rifaximin and Uses Thereof
Methods for Treating Irritable Bowel Syndrome (Ibs) and Infections
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Rifaximin Derivative and Uses Thereof
Controlled-Release Solid Dosage Forms of Mesalamine
Method of Stably Treating Incontinence Using a Bulking Agent
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Methods and Compositions for Treating Hiv-Associated Diarrhea
Methods of Administering Rifaximin Without Producing Antibiotic Resistance
Methods of Administering Rifaximin for Weight Loss and Treatment of Obesity
Methods of Improving Long-Term Survival and Reducing Hospitalization Readmission Rates for Subjects Suffering from Hepatic Encephalopathy
Methods of Using Rifaximin in Position Emission Tomography (Pet) Scans
2-Hydroxy-5-Phenylazobenzoic Acid Derivatives and Method of Treating Ulcerative Colitis Therewith
Patent: 4,412,992 →
Application: 06/281,504 →
Use of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives as Colon Cancer Chemopreventative and Chemotherapeutic Agents
Patent: 5,498,608 →
Application: 08/178,578 →
Use of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives as Colon Cancer Chemopreventative and Chemotherapeutic Agents
Patent: 5,905,073 →
Application: 08/669,377 →
Non-Aqueous Colonic Purgative Formulations
Patent: 6,162,464 →
Application: 08/829,080 →
New Formulations of Balsalazide and Its Derivatives
Patent: 6,197,341 →
Application: 09/068,823 →
Electrolyte Purgative
Patent: 7,993,682 →
Application: 10/506,728 →
Publication: US 2005/0271749
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
Application: 10/588,254 →
Publication: US 2008/0306029
Immediate-release formulations of acid-labile pharmaceutical compositions
Application: 10/896,682 →
Publication: US 2005/0112193
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
Application: 10/938,766 →
Publication: US 2005/0220870
Colonic Purgative Composition with Soluble Binding Agent
Patent: 7,687,075 →
Application: 10/988,693 →
Publication: US 2005/0129781
Rapidly dissolving metoclopramide solid oral dosage and method thereof
Application: 11/052,570 →
Publication: US 2005/0137265
Purgative composition and uses thereof
Application: 11/117,436 →
Publication: US 2006/0247180
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,906,940 →
Application: 11/138,763 →
Publication: US 2005/0266071
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,815,916 →
Application: 11/287,888 →
Publication: US 2006/0147522
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
Patent: 8,993,599 →
Application: 11/338,608 →
Publication: US 2006/0204585
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Patent: 8,921,344 →
Application: 11/592,854 →
Publication: US 2007/0167416
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Patent: 7,452,872 →
Application: 11/835,897 →
Publication: US 2007/0265232
Novel Formulations of Proton Pump Inhibitors and Methods of Using These Formulations
Application: 11/868,388 →
Publication: US 2009/0092658
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Patent: 7,625,884 →
Application: 11/877,589 →
Publication: US 2008/0096849
Amorphous Form of Rifaximin and Processes for Its Preparation
Patent: 7,709,634 →
Application: 11/902,211 →
Publication: US 2009/0082558
Polyethylene glycol colonic purgative composition
Application: 11/982,603 →
Publication: US 2008/0260682
Balsalazide formulations and manufacture and use thereof
Application: 12/072,112 →
Publication: US 2009/0252788
Colonic Purgative Composition with Soluble Binding Agent
Patent: 7,718,197 →
Application: 12/075,772 →
Publication: US 2008/0213393
Rifaximin Anti-Rectal Dysfunction Preparation
Patent: 8,987,292 →
Application: 12/224,774 →
Publication: US 2010/0048520
Compositions and Methods for the Treatment of Radiation Proctosigmoitis
Application: 12/309,893 →
Publication: US 2010/0069421
Forms of Rifaximin and Uses Thereof
Patent: 8,067,429 →
Application: 12/393,012 →
Publication: US 2010/0239664
Methods for Treating Diarrhea-Associated Irritable Bowel Syndrome
Patent: 8,309,569 →
Application: 12/393,979 →
Publication: US 2011/0118295
Methods of Treating Bowel Diseases by Administering a Bowel Cleanser and an Antibiotic
Application: 12/437,232 →
Publication: US 2009/0324736
Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
Application: 12/452,152 →
Publication: US 2010/0137580
Modulation of Systemic Exposure to Rifaximin
Application: 12/508,864 →
Publication: US 2010/0317681
Methods of Treating Hepatic Encephalopathy
Application: 12/572,344 →
Publication: US 2010/0204173
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Application: 12/628,072 →
Publication: US 2010/0087401
Forms of Rifaximin and Uses Thereof
Application: 12/676,756 →
Colonic Purgative Composition with Soluble Binding Agent
Patent: 8,507,009 →
Application: 12/690,384 →
Publication: US 2010/0159026
Forms of Rifaximin and Uses Thereof
Patent: 8,486,956 →
Application: 12/708,836 →
Publication: US 2010/0174064
Methods of Treating Hepatic Encephalopathy
Application: 12/792,658 →
Publication: US 2011/0035232
Pharmaceutical Formulation And Method For Treating Acid-Caused Gastrointestinal Disorders
Application: 12/847,938 →
Publication: US 2010/0297220
Forms of Rifaximin and Uses Thereof
Application: 12/868,322 →
Publication: US 2011/0105550
Methods for Treating Irritable Bowel Syndrome (Ibs)
Application: 12/880,739 →
Publication: US 2011/0065741
Methods of Treating Travelers Diarrhea and Hepatic Encephalopathy
Patent: 7,928,115 →
Application: 12/957,831 →
Publication: US 2011/0065740
Methods of Treating Hepatic Encephalopathy
Application: 12/964,847 →
Publication: US 2011/0071103
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Patent: 8,829,017 →
Application: 13/076,967 →
Publication: US 2011/0178113
Methods of Treating Hepatic Encephalopathy
Application: 13/077,373 →
Publication: US 2011/0243879
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Patent: 8,497,256 →
Application: 13/094,261 →
Publication: US 2012/0058184
Electrolyte Purgative
Application: 13/111,736 →
Publication: US 2011/0223252
Forms of Rifaximin and Uses Thereof
Patent: 8,513,275 →
Application: 13/152,804 →
Publication: US 2012/0108620
Forms of Rifaximin and Uses Thereof
Application: 13/165,410 →
Formulations of Rifaximin and Uses Thereof
Application: 13/181,481 →
Publication: US 2012/0077835
Forms of Rifaximin and Uses Thereof
Application: 13/226,053 →
Publication: US 2012/0076857
Compositions for Bowel Preparation and Methods of Use Thereof
Application: 13/246,287 →
Publication: US 2012/0021064
Methods and Compositions for Treating Hiv-Associated Diarrhea
Patent: 8,962,680 →
Application: 13/285,397 →
Publication: US 2012/0184605
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application: 13/294,307 →
Publication: US 2012/0107370
Forms of Rifaximin and Uses Thereof
Application: 13/368,917 →
Forms of Rifaximin and Uses Thereof
Patent: 8,735,419 →
Application: 13/371,238 →
Publication: US 2012/0207833
Forms of Rifaximin and Uses Thereof
Patent: 8,227,482 →
Application: 13/434,766 →
Publication: US 2012/0207832
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Patent: 9,192,616 →
Application: 13/439,594 →
Publication: US 2013/0065862
Methods of Treating Diseases with Proanthocyanidin Oligomers Such as Crofelemer
Application: 13/500,589 →
Publication: US 2012/0202876
Forms of Rifaximin and Uses Thereof
Patent: 8,507,517 →
Application: 13/530,386 →
Publication: US 2012/0264774
Electrolyte Purgative
Patent: 8,679,549 →
Application: 13/539,092 →
Publication: US 2012/0282339
Forms of Rifaximin and Uses Thereof
Patent: 8,569,326 →
Application: 13/587,537 →
Publication: US 2012/0316334
Methods for Treating Infection
Application: 13/587,539 →
Publication: US 2013/0210852
Forms of Rifaximin and Uses Thereof
Patent: 8,754,098 →
Application: 13/593,453 →
Publication: US 2013/0066079
Methods of Treating Bowel Diseases by Administering a Bowel Cleanser and an Antibiotic
Application: 13/603,647 →
Publication: US 2013/0164384
Forms of Rifaximin and Uses Thereof
Patent: 9,181,274 →
Application: 13/644,241 →
Publication: US 2014/0011828
Methods for Treating Bowel Diseases
Application: 13/650,188 →
Publication: US 2013/0137713
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Patent: 8,946,252 →
Application: 13/654,978 →
Publication: US 2013/0059875
Methods for Treating Irritable Bowel Syndrome (Ibs) and Infections
Application: 13/667,585 →
Publication: US 2013/0184302
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Application: 13/720,235 →
Publication: US 2013/0317050
Methods of Treating Hepatic Encephalopathy
Patent: 8,642,573 →
Application: 13/737,535 →
Publication: US 2013/0123209
Methods for Treating Irritable Bowel Syndrome (Ibs)
Patent: 9,566,270 →
Application: 13/755,578 →
Publication: US 2013/0203795
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 13/766,167 →
Publication: US 2013/0209559
Antibody Formulations
Application: 13/766,966 →
Publication: US 2013/0216556
Methods of Treating Hepatic Encephalopathy
Patent: 8,969,398 →
Application: 13/768,617 →
Publication: US 2013/0171090
Method of Stably Treating Incontinence Using a Bulking Agent
Application: 13/788,401 →
Publication: US 2014/0005142
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application: 13/840,861 →
Publication: US 2014/0163096
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 13/857,295 →
Publication: US 2013/0225537
Methods of Treating Hepatic Encephalopathy
Patent: 9,421,195 →
Application: 13/914,074 →
Publication: US 2013/0345166
Forms of Rifaximin and Uses Thereof
Patent: 9,034,892 →
Application: 13/929,003 →
Publication: US 2014/0141081
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Application: 13/938,777 →
Publication: US 2013/0295178
Forms of Rifaximin and Uses Thereof
Application: 13/949,684 →
Publication: US 2013/0310409
New Forms of Rifaximin and Uses Thereof
Patent: 8,815,888 →
Application: 13/955,660 →
Publication: US 2013/0317225
Process for Preparing Amorphous Rifaxmin and the Amorphous Rifaximin Thus Obtained
Application: 13/970,576 →
Publication: US 2013/0338355
Gastric and Colonic Formulations and Methods for Making and Using Them
Application: 13/993,294 →
Publication: US 2013/0296314
Antibody Formulations
Application: 14/015,039 →
Publication: US 2014/0010827
Forms of Rifaximin and Uses Thereof
Application: 14/031,731 →
Method of Stably Treating Incontinence Using a Bulking Agent
Application: 14/058,836 →
Publication: US 2014/0045788
Forms of Rifaximin and Uses Thereof
Patent: 9,273,066 →
Application: 14/062,333 →
Publication: US 2014/0179916
Pharmaceutical Formulation and Method for Treating Acid Caused Gastrointestinal Disorders
Application: 14/181,017 →
Publication: US 2014/0370104
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 14/197,849 →
Publication: US 2014/0187517
Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
Application: 14/218,508 →
Publication: US 2015/0011588
Formulations of Rifaximin and Uses Thereof
Patent: 9,737,610 →
Application: 14/250,293 →
Publication: US 2015/0133482
Method for Preparing a Rifaximin Product
Patent: 9,273,063 →
Application: 14/261,138 →
Publication: US 2015/0011750
Forms of Rifaximin and Uses Thereof
Application: 14/275,272 →
Forms of Rifaximin and Uses Thereof
Patent: 9,133,217 →
Application: 14/288,184 →
Publication: US 2015/0118307
Novel Formulations of Proton Pump Inhibitors and Methods of Using These Formulations
Application: 14/290,691 →
Publication: US 2014/0271853
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application: 14/307,175 →
Publication: US 2014/0294903
Rifaximin Derivative and Uses Thereof
Patent: 9,035,046 →
Application: 14/319,060 →
Publication: US 2014/0378495
Electrolyte Purgatives
Application: 14/353,744 →
Publication: US 2015/0056140
Method for Treating Intestinal Diseases Presenting at Least One Inflammatory Component
Application: 14/378,114 →
Publication: US 2015/0017239
Controlled-Release Solid Dosage Forms of Mesalamine
Application: 14/383,462 →
Publication: US 2015/0056275
Formulations and Methods of Manufacturing Formulations for Use in Colonic Evacuation
Application: 14/417,172 →
Publication: US 2015/0272937
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
Application: 14/467,741 →
Publication: US 2015/0044303
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Application: 14/509,446 →
Publication: US 2015/0132381
Forms of Rifaximin and Uses Thereof
Patent: 9,359,357 →
Application: 14/580,458 →
Publication: US 2015/0299199
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Patent: 9,629,828 →
Application: 14/605,109 →
Publication: US 2015/0141450
Methods of Treating Hepatic Encephalopathy
Patent: 9,629,829 →
Application: 14/612,697 →
Publication: US 2015/0157612
Colonic purgative composition with soluble binding agent
Application: 60/523,142 →
Prevention, treatment, and amelioration of radiation induced enteritis
Application: 60/608,951 →
Polyethylene glycol colonic purgative composition
Application: 60/678,181 →
Balsalazide formulations and manufacture and use thereof
Application: 60/711,300 →
Rifaximin anti-rectal dysfunction preparation
Application: 60/781,144 →
Rifaximin anti-rectal dysfunction preparation
Application: 60/791,236 →
Compositions and methods for the treatment of radiation proctosigmoitis
Application: 60/835,273 →
Compositions and methods for the treatment of radiation proctosigmoitis
Application: 60/850,299 →
Polymorphic Forms of Rifaximin and Uses Thereof
Application: 61/031,329 →
Methods for Treating Bowel Diseases
Application: 61/031,679 →
Methods of Treating Bowel Diseases by Administering a Bowel Cleanser and an Antibiotic
Application: 61/051,341 →
Compositions and Methods for Treating Hepatic Encephalopathy Using Rifaximin
Application: 61/102,349 →
Methods for Treating Bowel Diseases
Application: 61/102,801 →
Compositions of Bowel Preparation and Methods of Use Thereof
Application: 61/164,381 →
Methods for the Diagnosis and Treatment of Disease
Application: 61/183,513 →
Modulation of Systemic Exposure to Rifaximin
Application: 61/187,251 →
Methods for Treating Irritable Bowel Syndrome (Ibs)
Application: 61/241,945 →
Methods of Treating Diseases with Proanthocyanidin Oligomer Such as Crofelemer
Application: 61/249,236 →
Methods for Irritable Bowel Syndrome (Ibs)
Application: 61/262,475 →
Methods for Treating Hepatic Encephalopathy
Application: 61/262,525 →
Modulation of Systemic Exposure to Rifaximin
Application: 61/297,696 →
Methods for Treating Infection
Application: 61/305,832 →
Methods of Treating Hepatic Encephalopathy
Application: 61/305,854 →
Methods of Treating Hepatic Encephalopathy
Application: 61/306,935 →
Methods of Treating Hepatic Encephalopathy
Application: 61/307,417 →
Methods of Treating Hepatic Encephalopathy
Application: 61/316,796 →
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Application: 61/328,151 →
Methods for Irritable Bowel Syndrome (Ibs)
Application: 61/329,511 →
Forms of Rifaximin and Uses Thereof
Application: 61/351,281 →
Forms of Rifaximin and Uses Thereof
Application: 61/357,505 →
Forms of Rifaximin and Uses Thereof
Application: 61/363,241 →
Forms of Rifaximin and Uses Thereof
Application: 61/363,511 →
Formulations of Rifaximin and Uses Thereof
Application: 61/363,609 →
Forms of Rifaximin and Uses Thereof
Application: 61/367,185 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application: 61/408,622 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application: 61/409,335 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application: 61/416,249 →
Forms of Rifaximin and Uses Thereof
Application: 61/416,593 →
Formulations of Rifaximin and Uses Thereof
Application: 61/419,056 →
Methods and Compositions for Treating HIV-Associated Diarrhea
Application: 61/434,379 →
Forms of Rifaximin and Uses Thereof
Application: 61/441,902 →
Forms of Rifaximin and Uses Thereof
Application: 61/530,905 →
Methods and Compositions for Treating Ibs
Application: 61/554,662 →
Polymorphic Form Mu of Rifaximin
Application: 61/556,649 →
Methods and Compositions for Treating Ibs
Application: 61/559,686 →
Methods for Treating C. Difficle Infection (Cdi)
Application: 61/560,128 →
Methods and Compositions for Treating Irritable Bowel Syndrome (Ibs)
Application: 61/560,133 →
Methods and Compositions for Treating Irritable Bowel Syndrome (Ibs)
Application: 61/560,267 →
Methods for Treating C. Difficile Infection (Cdi)
Application: 61/560,273 →
Methods and Compositions for Treating Ibs
Application: 61/560,788 →
Methods of Reducing Commonly Occurring Infections in Hepatic Encephalopathy
Application: 61/563,033 →
Methods for Treating C. Difficile Infection (Cdi)
Application: 61/564,270 →
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Application: 61/577,654 →
Polymorphic Form Pi of Rifaximin
Application: 61/583,024 →
Rifaximin Derivative and Uses Thereof
Application: 61/590,516 →
Methods for Treating Ibs-D
Application: 61/600,635 →
Controlled-Release Solid Dosage Forms of Mesalamine
Application: 61/607,726 →
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Application: 61/649,268 →
Method of Stably Treating Incontinence Using a Bulking Agent
Application: 61/665,846 →
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Application: 61/682,154 →
Methods of Administering Rifaximin Without Producing Antibiotic Resistance
Application: 61/700,151 →
Methods of Improving Long-Term Survival and Reducing Hospitalization Readmission Rates for Subjects Suffering from Hepatic Encephalopathy
Application: 61/700,862 →
Methods of Administering Rifaximin for Weight Loss and Treatment of Obesity
Application: 61/700,866 →
Method of Stably Treating Incontinence Using a Bulking Agent
Application: 61/731,774 →
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application: 61/734,901 →
Methods of Using Rifaximin in Position Emission Tomography (Pet) Scans
Application: 61/824,780 →
Treatment of Hereditary Angioedema with C1 Inhibitor
Application: 61/946,677 →
IBS Microbiota and Uses Thereof
Application: 61/988,293 →
IBS Microbiota and Uses Thereof
Application: 61/988,841 →
Method of Decreasing the Risk of a Cardiovascular Event
Application: 62/010,415 →
Method of Decreasing the Risk of a Cardiovascular Event
Application: 62/010,997 →
Method of Decreasing the Risk of a Cardiovascular Event
Application: 62/011,007 →
Methods for Retreating Irritable Bowel Syndrome (Ibs)
Application: 62/019,388 →
Hydroxy-(R),(R)-2,2'-Bismethylnaltrexones and Uses Thereof
Application: 62/027,852 →
Ibs Microbiota and Uses Thereof
Application: 62/036,085 →
Methods for Retreating Irritable Bowel Syndrome (Ibs)
Application: 62/036,097 →
Ibs Microbiota and Uses Thereof
Application: 62/135,658 →
Related Assignments (18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 8, 2013
From: WU, YIDUO; PARENT, STEPHAN D.; SCHULTHEISS, NATHAN CARL; BEVILL, MELANIE JANELLE
To: APTUIT, INC.
Reel/Frame 030750/0317 →
Assignment of Assignor's Interest Nov 5, 2013
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; CONFORTINI, DONATELLA; BARBANTI, MIRIAM
To: ALFA WASSERMANN S.P.A.
Reel/Frame 031542/0474 →
Assignment of Assignor's Interest Nov 5, 2013
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 031542/0423 →
Assignment of Assignor's Interest Dec 26, 2013
From: CHANG, CHRISTOPHER; PIMENTEL, MARK
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 031847/0529 →
Security Agreement Jan 2, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031896/0752 →
Security Agreement Jan 2, 2014
From: SANTARUS, INC.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031910/0545 →
Security Agreement Jan 2, 2014
From: SALIX PHARMACEUTICALS, INC.
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 031901/0283 →
Assignment of Assignor's Interest Jan 27, 2014
From: BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 032053/0477 →
Assignment of Assignor's Interest Oct 28, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: DR. FALK PHARMA GMBH
Reel/Frame 034052/0334 →
Assignment of Assignor's Interest Mar 26, 2015
From: FORBES, WILLIAM; BORTEY, ENOCH; GOLDEN, PAM
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035264/0014 →
Release of Security Interest Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 035356/0519 →
Release of Security Interest Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SANTARUS, INC.
Reel/Frame 035353/0836 →
Release of Security Interest Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035353/0661 →
Assignment of Assignor's Interest Aug 20, 2015
From: NEFF, GUY
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 036406/0956 →
Intellectual Property Security Agreement Feb 12, 2016
From: JAGUAR ANIMAL HEALTH, INC.
To: HERCULES TECHNOLGY GROWTH CAPITAL, INC., AS AGENT
Reel/Frame 037809/0161 →
Assignment of Assignor's Interest Mar 7, 2016
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 037910/0987 →
Assignment of Assignor's Interest Apr 1, 2016
From: SALIX PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 038168/0355 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →